Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poli Ind Chimica SpafiledCriticalPoli Ind Chimica Spa
Priority to IT92MI2801priorityCriticalpatent/IT1256635B/en
Publication of ITMI922801A0publicationCriticalpatent/ITMI922801A0/en
Priority to PCT/EP1993/003400prioritypatent/WO1994013691A1/en
Priority to AU56955/94Aprioritypatent/AU5695594A/en
Priority to IL10790393Aprioritypatent/IL107903A0/en
Priority to MX9307794Aprioritypatent/MX9307794A/en
Publication of ITMI922801A1publicationCriticalpatent/ITMI922801A1/en
Application grantedgrantedCritical
Publication of IT1256635BpublicationCriticalpatent/IT1256635B/en
IT92MI28011992-12-101992-12-10New 3-(thi)-oxo-4-aza-androstane derivs - used as testosterone 5-alpha-reductase inhibitors for treating super-androgenic conditions e.g. acne or prostate carcinoma.
IT1256635B
(en)
New 3-(thi)-oxo-4-aza-androstane derivs - used as testosterone 5-alpha-reductase inhibitors for treating super-androgenic conditions e.g. acne or prostate carcinoma.
New 3-(thi)-oxo-4-aza-androstane derivs - used as testosterone 5-alpha-reductase inhibitors for treating super-androgenic conditions e.g. acne or prostate carcinoma.
New 3-(thi)-oxo-4-aza-androstane derivs - used as testosterone 5-alpha-reductase inhibitors for treating super-androgenic conditions e.g. acne or prostate carcinoma.